Description
Thymosin Alpha-1 (Tα1)
Thymosin Alpha-1 (Tα1) is a synthetic peptide derived from a naturally occurring thymic hormone fragment originally isolated from thymosin fraction 5. It is widely utilized in laboratory and preclinical research focused on immune system signaling, cellular regulation, and cytokine-mediated biological pathways.
The peptide consists of 28 amino acids and is known for its role in research involving T-cell maturation, antigen presentation processes, and immune signaling networks. In experimental settings, Thymosin Alpha-1 has been studied for its interactions with immune regulatory pathways that coordinate innate and adaptive immune responses.
Due to its involvement in immune signaling processes, Thymosin Alpha-1 is frequently used in cell culture and immunology research models examining cytokine production, dendritic cell activity, and lymphocyte regulation. Preclinical studies have explored how thymic peptides may influence immune cell differentiation, cellular signaling cascades, and inflammatory pathway regulation within controlled research environments.
Rather than targeting a single molecular mechanism, Thymosin Alpha-1 is studied for its broad immunoregulatory signaling behavior, making it a compound of ongoing interest for researchers investigating complex immune communication networks and host defense signaling pathways.
Peptide Identity and Molecular Profile
| Property |
Description |
| Peptide Name |
Thymosin Alpha-1 |
| Full Name |
Thymosin α1 |
| Peptide Class |
Synthetic thymic peptide |
| Amino Acid Length |
28 residues |
| Peptide Sequence |
Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH |
| Molecular Weight |
~3,108 Da |
| Biological Origin |
Synthetic analog of thymic hormone peptide |
Chemical and Registry Information
| Property |
Value |
| Molecular Formula |
C₁₂₉H₂₁₅N₃₃O₅₅ |
| CAS Number |
62304-98-7 |
| PubChem CID |
16132346 |
| Synonyms |
Thymosin α1, Tα1, Thymalfasin |
Biological Pathways Studied (Preclinical Research)
In laboratory and preclinical research environments, Thymosin Alpha-1 has been studied for interactions with multiple immune regulatory pathways. These investigations focus on molecular and cellular mechanisms rather than clinical outcomes.
| Pathway / System |
Research Context |
| T-Cell Signaling |
Studied in relation to T-cell differentiation and activation |
| Cytokine Regulation |
Investigated in immune signaling and inflammatory pathway models |
| Dendritic Cell Activity |
Explored in antigen presentation and immune communication studies |
| Toll-Like Receptor (TLR) Pathways |
Examined in innate immune signaling research |
| Immune System Modulation |
Studied in models of host defense and immune coordination |
Research Applications
Thymosin Alpha-1 is commonly used in laboratory research involving:
• Immunology and immune signaling studies
• Cytokine pathway investigations
• T-cell maturation and lymphocyte regulation research
• Host defense and immune response models
• Cellular signaling research in immune cell populations
Storage and Handling Guidelines
Store Thymosin Alpha-1 in a cool, dry place protected from light to maintain peptide stability. Appropriate laboratory storage conditions should be maintained to preserve molecular integrity. Handle all research peptides using standard laboratory safety protocols.
Lyophilized Powder
Thymosin Alpha-1 is supplied in lyophilized powder form, produced through freeze-drying to remove residual moisture while preserving peptide structure and chemical stability. This format supports accurate measurement and reproducibility in controlled research protocols.
Shelf Life After Reconstitution
Once reconstituted, Thymosin Alpha-1 is no longer in its lyophilized state, and its stability characteristics differ from those of the dry powder. In laboratory research settings, reconstituted peptide material is typically regarded as having a short-term usable shelf life, commonly measured in days rather than weeks.
Researchers typically account for post-reconstitution stability as part of experimental planning and laboratory quality control procedures. Stability may vary depending on environmental conditions and storage parameters.
Thymosin Alpha-1 Research Overview
Thymosin Alpha-1 (Tα1) is a synthetic 28–amino-acid peptide originally derived from thymosin fraction 5, a group of thymic peptides identified in thymus tissue extracts. The peptide sequence Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH has a molecular weight of approximately 3,108 Da and molecular formula C₁₂₉H₂₁₅N₃₃O₅₅.
In laboratory and preclinical research settings, Thymosin Alpha-1 is utilized to investigate immune signaling, T-cell differentiation, cytokine regulation, and innate immune pathway activation. Experimental studies have explored its activity across lymphocyte populations, dendritic cells, and antigen-presenting systems, focusing on immune communication networks and regulatory signaling mechanisms.
Research literature describes Thymosin Alpha-1 as a pleiotropic immunoregulatory peptide, meaning it influences multiple cellular signaling pathways rather than acting through a single molecular target. Laboratory investigations therefore emphasize its role in immune pathway modulation, cytokine signaling networks, and host defense signaling systems rather than therapeutic outcomes.
Note: All mechanistic insights derive from laboratory or animal models. This compound is research-use only and not intended for human or veterinary application.
Mechanism of Action in Laboratory Models
Thymosin Alpha-1 has been investigated in several preclinical immune signaling pathways.
T-Cell Differentiation and Activation
Laboratory models examine the influence of Thymosin Alpha-1 on T-cell maturation, activation markers, and immune signaling pathways, typically using lymphocyte culture systems and immunological assays (Goldstein & Badamchian, 2004).
Cytokine Regulation
Preclinical research evaluates interactions with cytokine signaling networks, including pathways involving interleukins and interferon-associated immune responses in immune cell culture models.
Dendritic Cell Signaling
Studies investigate how Thymosin Alpha-1 may influence dendritic cell maturation and antigen presentation mechanisms, processes central to immune system communication and adaptive immune responses.
Toll-Like Receptor (TLR) Pathways
Laboratory assays examine interactions with Toll-like receptor signaling, particularly pathways associated with innate immune recognition and host defense signaling cascades.
Primary Research Findings
Mechanistic studies in preclinical and in vitro models demonstrate several areas of investigation.
Immune Cell Signaling
Experimental research evaluates how Thymosin Alpha-1 influences T-lymphocyte activation and immune cell communication, particularly in models of immune pathway signaling (Goldstein & Badamchian, 2004).
Cytokine Network Regulation
Laboratory studies examine cytokine expression patterns and immune signaling pathways associated with interleukin and interferon signaling systems.
Innate Immune Pathway Activation
Research involving dendritic cells and innate immune models investigates how thymic peptides interact with pattern recognition receptors and host defense signaling pathways.
Note: Reported effects represent mechanistic observations in laboratory research; direct clinical translation is not established.
Research Applications
Immunology and Immune Signaling Research
Investigations include T-cell activation, lymphocyte differentiation, and immune communication networks.
Cytokine and Inflammatory Pathway Studies
Laboratory models examine cytokine signaling, immune pathway regulation, and host defense responses.
Cellular Communication Research
Studies explore immune system coordination through antigen presentation and dendritic cell signaling mechanisms.
Comparative Research Context
Thymosin Alpha-1 is frequently evaluated in comparison with other thymic peptides and immune-modulating signaling molecules.
Comparative research focuses on immune pathway signaling, cytokine regulation, and lymphocyte activation mechanisms in vitro or in animal models rather than functional superiority.
Research Handling and Format
Lyophilized Powder: Provided freeze-dried to support chemical stability and reproducibility.
Storage: Maintain in a cool, dry, light-protected environment.
Reconstitution: Stability post-reconstitution is short-term and laboratory-condition dependent.
Research Use Only: Intended solely for laboratory research purposes.
Peptide Identity and Molecular Profile
| Property |
Description |
| Peptide Name |
Thymosin Alpha-1 |
| Peptide Class |
Synthetic thymic peptide |
| Amino Acid Sequence |
Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH |
| Amino Acid Length |
28 residues |
| Molecular Weight |
~3,108 Da |
| Molecular Formula |
C₁₂₉H₂₁₅N₃₃O₅₅ |
| Research Role |
Preclinical studies on immune signaling, cytokine pathways, and T-cell regulation |
References
Goldstein, A. L., & Badamchian, M. (2004). Thymosins: chemistry and biological properties in health and disease. Expert Opinion on Biological Therapy, 4(4), 559–573. https://doi.org/10.1517/14712598.4.4.559
Romani, L., et al. (2007). Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling. Blood, 109(12), 5049–5056. https://doi.org/10.1182/blood-2006-11-056994
Garaci, E. (2007). Thymosin alpha-1: a historical overview. Annals of the New York Academy of Sciences, 1112, 14–20. https://doi.org/10.1196/annals.1415.002
Note: Current understanding of Thymosin Alpha-1 derives primarily from mechanistic and preclinical studies. Clinical outcomes remain outside the scope of laboratory research descriptions.
